The global non-alcoholic steatohepatitis treatment market size is calculated at USD 7.75 billion in 2024, grew to USD 9.93 billion in 2025, and is projected to reach around USD 92.5 billion by 2034. The market is expanding at a CAGR of 28.14% between 2025 and 2034.